Our Mission
BIONCaRT GmbH has been actively engaged in the biotechnology and life sciences sector, with a strong focus on regenerative medicine applications. As a research-driven pharmaceutical company, we specialize in the development of advanced biomedical therapies for clinical use in humans—particularly for the treatment of orthopedic conditions. Our primary emphasis lies in the development, regulatory approval, and manufacturing of allogeneic, stem cell-based medicinal products.
BionPlanta - today BIONCaRT / CartiCure - today MesemCart
Foundation of BioPlanta GmbH and Start of Development of an Allogeneic Cell Therapy Product from Mesenchymal Stromal Cells (MesemCart)
Successful Preclinical Safety Testing in the Mouse Model
IQ Innovation Award Central Germany
Renaming to BIONCaRT GmbH
Start of the Phase I/IIa Clinical Trial for the Market Approval of MesemCart for the Treatment of Focal Cartilage Damage in the Knee Joint
Planned Market Entry in Germany
Planned European Market Approval
Planned Approval by the FDA (U.S. Food and Drug Administration)
BIONCaRT Management
Dr. André Gerth
Dr. André Gerth brings extensive leadership experience in small and medium-sized biotech enterprises. With a strong track record in corporate development, he is recognized as a trusted and capable partner within the industry. His in-depth expertise in international B2B business spans European, Central and South American, and Asian markets. As a dedicated advocate of biotechnology, Dr. Gerth drives innovation and supports companies in achieving their strategic goals.
Dr. Heike Opitz
Dr. Heike Opitz brings extensive experience in managing collaborative projects and overseeing the planning and execution of research and development (R&D) initiatives. Her expertise lies particularly in the development and regulatory approval of stem cell therapies and medical products.
Thank you for your interest in joining BIONCaRT. While we currently have no open positions, we appreciate your enthusiasm and encourage you to check back regularly — new opportunities may arise at any time!

